Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liam R Brunham

Showing results (41-50 of 156) with videos related to

Pageof 16
Sort By:
Journal of Clinical Lipidology|December 4, 2018
Diagnostic accuracy of ultrasound and MRI for Achilles tendon xanthoma in people with familial hypercholesterolemia: A systematic reviewAlex Scott, Thomas Michael Zahradnik, Kipling Squier, et al.
Journal of the American Heart Association|May 6, 2026
Temporal Trends in Lipid-Lowering Therapy Use and Adherence in Patients With Premature Coronary Artery DiseaseDiana N Vikulova, Danielle Pinheiro-Muller, Simon N Pimstone, et al.
The Journal of Clinical Endocrinology and Metabolism|April 16, 2024
Prevalence of Dysbetalipoproteinemia in the UK Biobank According to Different Diagnostic CriteriaMartine Paquette, Mark Trinder, Simon-Pierre Guay, et al.
Current Diabetes Reports|April 29, 2010
Cholesterol in beta-cell dysfunction: the emerging connection between HDL cholesterol and type 2 diabetesLiam R Brunham, Janine K Kruit, Michael R Hayden, et al.
Current Opinion in Lipidology|May 14, 2010
HDL and LDL cholesterol significantly influence beta-cell function in type 2 diabetes mellitusJanine K Kruit, Liam R Brunham, C Bruce Verchere, et al.
The Journal of Clinical Investigation|February 5, 2008
Cholesterol in islet dysfunction and type 2 diabetesLiam R Brunham, Janine K Kruit, C Bruce Verchere, et al.
The Journal of Clinical Endocrinology and Metabolism|September 7, 2024
Predictors of Cardiovascular Disease in Individuals With Dysbetalipoproteinemia: A Prospective Study in the UK BiobankMartine Paquette, Mark Trinder, Simon-Pierre Guay, et al.
Pharmacogenetics and Genomics|August 1, 2015
Pharmacogenetic versus clinical dosing of warfarin in individuals of Chinese and African-American ancestry: assessment using data simulationNicholas L X Syn, Soo-Chin Lee, Liam R Brunham, et al.
Atherosclerosis|December 15, 2021
Polygenic architecture and cardiovascular risk of familial combined hyperlipidemiaMark Trinder, Diana Vikulova, Simon Pimstone, et al.
The Canadian Journal of Cardiology|December 29, 2020
The Interplay Between Titin, Polygenic Risk, and Modifiable Cardiovascular Risk Factors in Atrial FibrillationKate Huang, Mark Trinder, Thomas M Roston, et al.
Pageof 16

Showing results (41-50 of 156) with videos related to

Sort By:
Pageof 16
Journal of Clinical Lipidology|December 4, 2018
Diagnostic accuracy of ultrasound and MRI for Achilles tendon xanthoma in people with familial hypercholesterolemia: A systematic reviewAlex Scott, Thomas Michael Zahradnik, Kipling Squier, et al.
Journal of the American Heart Association|May 6, 2026
Temporal Trends in Lipid-Lowering Therapy Use and Adherence in Patients With Premature Coronary Artery DiseaseDiana N Vikulova, Danielle Pinheiro-Muller, Simon N Pimstone, et al.
The Journal of Clinical Endocrinology and Metabolism|April 16, 2024
Prevalence of Dysbetalipoproteinemia in the UK Biobank According to Different Diagnostic CriteriaMartine Paquette, Mark Trinder, Simon-Pierre Guay, et al.
Current Diabetes Reports|April 29, 2010
Cholesterol in beta-cell dysfunction: the emerging connection between HDL cholesterol and type 2 diabetesLiam R Brunham, Janine K Kruit, Michael R Hayden, et al.
Current Opinion in Lipidology|May 14, 2010
HDL and LDL cholesterol significantly influence beta-cell function in type 2 diabetes mellitusJanine K Kruit, Liam R Brunham, C Bruce Verchere, et al.
The Journal of Clinical Investigation|February 5, 2008
Cholesterol in islet dysfunction and type 2 diabetesLiam R Brunham, Janine K Kruit, C Bruce Verchere, et al.
The Journal of Clinical Endocrinology and Metabolism|September 7, 2024
Predictors of Cardiovascular Disease in Individuals With Dysbetalipoproteinemia: A Prospective Study in the UK BiobankMartine Paquette, Mark Trinder, Simon-Pierre Guay, et al.
Pharmacogenetics and Genomics|August 1, 2015
Pharmacogenetic versus clinical dosing of warfarin in individuals of Chinese and African-American ancestry: assessment using data simulationNicholas L X Syn, Soo-Chin Lee, Liam R Brunham, et al.
Atherosclerosis|December 15, 2021
Polygenic architecture and cardiovascular risk of familial combined hyperlipidemiaMark Trinder, Diana Vikulova, Simon Pimstone, et al.
The Canadian Journal of Cardiology|December 29, 2020
The Interplay Between Titin, Polygenic Risk, and Modifiable Cardiovascular Risk Factors in Atrial FibrillationKate Huang, Mark Trinder, Thomas M Roston, et al.
Pageof 16